sarcosine-methyl-d3

Modify Date: 2024-01-05 17:55:34

sarcosine-methyl-d3 Structure
sarcosine-methyl-d3 structure
Common Name sarcosine-methyl-d3
CAS Number 118685-91-9 Molecular Weight 92.11170
Density 1.13g/cm3 Boiling Point 195.1ºC at 760 mmHg
Molecular Formula C3H4D3NO2 Melting Point 208ºC (dec.)(lit.)
MSDS USA Flash Point 71.8ºC

 Use of sarcosine-methyl-d3


Sarcosine-d3 (N-Methylglycine-d3) is the deuterium labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia[1][2].

 Names

Name sarcosine-methyl-d3
Synonym More Synonyms

 sarcosine-methyl-d3 Biological Activity

Description Sarcosine-d3 (N-Methylglycine-d3) is the deuterium labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia[1][2].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Mei-Yi Lee, et al. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci. 2017; 24: 18.

[3]. Katarzyna Socała, et al. Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models. Pharmacol Rep. Mar-Apr 2010;62(2):392-7.

[4]. Mei-Yi Lee, et al. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci. 2017; 24: 18.

[5]. Katarzyna Socała, et al. Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models. Pharmacol Rep. Mar-Apr 2010;62(2):392-7.

 Chemical & Physical Properties

Density 1.13g/cm3
Boiling Point 195.1ºC at 760 mmHg
Melting Point 208ºC (dec.)(lit.)
Molecular Formula C3H4D3NO2
Molecular Weight 92.11170
Flash Point 71.8ºC
Exact Mass 92.06650
PSA 49.33000
Vapour Pressure 0.184mmHg at 25°C
Index of Refraction 1.431

 Safety Information

RIDADR NONH for all modes of transport
WGK Germany 3

 Synthetic Route

~%

sarcosine-methyl-d3 Structure

sarcosine-methyl-d3

CAS#:118685-91-9

Literature: MacKenzie; Abeles Journal of Biological Chemistry, 1956 , vol. 222, p. 145,148

 Precursor & DownStream

Precursor  1

DownStream  0

 Synonyms

n-Tridecyloxyessigsaeure-methylester
MFCD01075434
N-trideuteriomethyl-glycine
N-Methyl-d3-glycine